Parents look for a place where their child will be loved and happy, but often have to make decisions based on cost and location. Researchers are looking for a rich developmental experience.

Three former leaders of an influential task force that issues guidelines for preventive care says insurance coverage for highly rated tests and services shouldn't be mandatory.

The federal Medicaid program had accused Mylan of underpaying required rebates for the EpiPen, which is used to reverse serious allergic reactions. The company said it committed no wrongdoing.

The deal to fight the mosquito-borne virus came after lawmakers dropped a controversial provision to block payments to Planned Parenthood for women's health care.

In testimony prepared for a congressional hearing, Mylan CEO Heather Bresch says the company makes about $50 in profit on each EpiPen. Analysts say it's still a hefty margin.

Bosses are passing more of the cost of health insurance on to workers in an effort to keep spending under control. But that can be unfair to lower-income employees, who pay disproportionately more.

A Wisconsin clinic provides free dental care so that poor rural residents can get their teeth fixed. But in most states people aren't so lucky. Millions of people have no access to dental care.

What if you had cavities and gum disease and couldn't find a dentist to treat you? That's the reality for millions of poor people who live in rural areas and have little or no access to dental care.

Manufacturers didn't provide data showing the chemicals are safe and effective, the FDA says. It says there's no evidence that they do a better job at preventing illness than plain soap and water.

That's what 76 percent said in a recent Kaiser Family Foundation survey. Half the respondents also said they'd be uncomfortable traveling to places in Florida where mosquitoes are spreading Zika.

Mylan's move comes amid pressure from consumers and Congress to lower the allergy drug's price. In less than 10 years, the price has risen from about $100 to more than $600 for an injector two-pack.

Lawmakers are demanding answers after the maker of an allergy treatment raised the price from about $100 per pack to about $600 per pack in seven years. Parents say they can't afford it.

EpiPen, the new poster child for prescription drug price gouging, may find that offering discount coupons isn't enough to mollify its critics in Congress and online.

Lawmakers are demanding answers as to why the price of EpiPens, which are used to stop life-threatening allergic reaction, keeps going up. The company said Thursday it will reimburse some of the cost.

Repeated extensions of drug patents help fend off competitors, researchers say, keeping prices high. And the fact that Medicare and Medicaid can't negotiate for discounts doesn't help, either.

The exit of insurers from exchanges created by the Affordable Care Act represents a fresh challenge to the viability of the president's signature health care law.

Insurers have released the latest lists of prescription drugs they won't cover in 2017. Express Scripts is excluding 85 drugs and CVS Caremark, 131. Some drugs for diabetes and asthma are out.

Drugs that consist of proteins and antibodies typically made by living organisms represent the new frontier in drug industry competition.

The state took Suboxone strips for treatment of opioid abuse off the list of approved drugs for Medicaid. Some patients say the alternatives aren't working for them.

Congress approved an amalgam of more than a dozen proposals that will expand access to medication-assisted treatment. It also will encourage police to send drug users to treatment rather than to jail.